Organovo Holdings Inc (ONVO)
1.10
-0.06
(-5.58%)
USD |
NASDAQ |
Apr 19, 16:00
1.14
+0.04
(+3.64%)
After-Hours: 17:00
Organovo Holdings Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2019 | 95.64% |
| September 30, 2019 | 78.54% |
| June 30, 2019 | 92.37% |
| March 31, 2019 | 85.15% |
| December 31, 2018 | 82.54% |
| September 30, 2018 | 86.74% |
| June 30, 2018 | 82.58% |
| March 31, 2018 | 74.39% |
| Date | Value |
|---|---|
| December 31, 2017 | 83.35% |
| September 30, 2017 | 81.25% |
| June 30, 2017 | 69.60% |
| March 31, 2017 | 77.46% |
| December 31, 2016 | 81.58% |
| September 30, 2016 | 71.44% |
| June 30, 2016 | 81.14% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
78.54%
Minimum
Sep 2019
95.64%
Maximum
Dec 2019
88.85%
Average
92.37%
Median
Jun 2019
Gross Profit Margin (Quarterly) Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 81.54% |
| IGC Pharma Inc | 65.20% |
| NovaBay Pharmaceuticals Inc | 48.70% |
| Protalix BioTherapeutics Inc | 15.54% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -149.0% |
| Return on Assets | -119.0% |
| Return on Invested Capital | -149.0% |
| Profit Margin (Quarterly) | -72.08K% |
| Operating Margin (Quarterly) | -73.60K% |
| Return on Net Operating Assets | -761.7% |